Good afternoon :)
Place Order
Add to Watchlist

Natural Capsules Ltd

NATCAPSUQ Share Price

214.891.75% (-3.83)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹226 cr, stock is ranked 2,387

High Risk

Stock is 3.29x as volatile as Nifty

NATCAPSUQ Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹226 cr, stock is ranked 2,387

High Risk

Stock is 3.29x as volatile as Nifty

NATCAPSUQ Performance & Key Metrics

NATCAPSUQ Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
370.910.99—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.976.460.64%

NATCAPSUQ Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

NATCAPSUQ Company Profile

Natural Capsules Limited makes hard gelatin capsule shells, hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Investor Presentation

View older View older 

May 31, 2025

PDF
View Older Presentations

NATCAPSUQ Similar Stocks (Peers)

Compare with peers Compare with peers 

NATCAPSUQ Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
36.88
36.88
1Y Return
7.93%
7.93%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.14
23.14
1Y Return
1.58%
1.58%
Buy Reco %
73.33
73.33
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
59.36
59.36
1Y Return
16.29%
16.29%
Buy Reco %
70.83
70.83
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.28
19.28
1Y Return
0.28%
0.28%
Buy Reco %
55.17
55.17
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
22.21
22.21
1Y Return
13.73%
13.73%
Buy Reco %
44.44
44.44
Compare with Peers

NATCAPSUQ Sentiment Analysis

NATCAPSUQ Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

NATCAPSUQ Stock Summary · June 2025

The company is poised for growth in the HPMC capsule segment, particularly in the U.S. market, driven by favorable tariff conditions and a projected revenue increase from Rs. 9 crores to Rs. 27 crores in FY'26. However, it faces significant challenges, including an 88.88% decline in profit after tax for FY'25 and operational difficulties reflected in a 12.01% drop in EBITDA. While regulatory approvals are underway to enhance market positioning, the API segment grapples with pricing pressures due to overcapacity in China. Despite these hurdles, management remains optimistic about improving profitability through strategic investments and capacity enhancements, aiming for a 10% to 15% overall revenue growth.

NATCAPSUQ Stock Growth Drivers
NATCAPSUQ Stock Growth Drivers
7
  • HPMC Capsule Business Growth

    The company has successfully established its HPMC capsule business, demonstrating stability and growth potential. In

  • Operational Capacity and Efficiency Improvements

    The company has achieved full capacity utilization in its API facility, which is expected to

NATCAPSUQ Stock Challenges
NATCAPSUQ Stock Challenges
4
  • Declining Profitability

    The company reported a significant decline in profitability, with profit after tax for Q4 FY'25

  • Challenges in API Market

    The company faces significant challenges in the API market, including a notable decline in API

NATCAPSUQ Forecast

NATCAPSUQ Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

NATCAPSUQ

NATCAPSUQ

Income

Balance Sheet

Cash Flow

NATCAPSUQ Income Statement

NATCAPSUQ Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 22.14%, vs industry avg of 10.22%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.02% to 0.04%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -6.2%, vs industry avg of 20.11%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue55.5760.9262.5082.42136.08172.94157.36169.91169.91
Raw Materialssubtract23.5422.8027.9236.1057.9983.8685.48151.69151.69
Power & Fuel Costsubtract6.798.898.168.5111.9013.7515.19
Employee Costsubtract5.235.575.916.978.489.5111.00
Selling & Administrative Expensessubtract9.478.898.999.7616.9523.0017.80
Operating & Other expensessubtract4.198.975.137.0814.256.895.89
Depreciation/Amortizationsubtract4.333.204.124.315.047.218.679.129.12
Interest & Other Itemssubtract0.330.530.910.542.083.735.276.316.32
Taxes & Other Itemssubtract0.570.140.522.245.476.552.502.182.17
EPS1.472.541.119.0919.0522.645.970.220.65
DPS0.820.820.490.821.001.000.000.000.00
Payout ratio0.560.320.450.090.050.040.000.000.00
See Costs

NATCAPSUQ Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 31PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 28PDF
Oct 28PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Nov 1PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

NATCAPSUQ Stock Peers

NATCAPSUQ Past Performance & Peer Comparison

NATCAPSUQ Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Natural Capsules Ltd370.910.99—
Sun Pharmaceutical Industries Ltd36.885.56—
Cipla Ltd23.143.901.06%
Torrent Pharmaceuticals Ltd59.3614.95—

NATCAPSUQ Stock Price Comparison

Compare NATCAPSUQ with any stock or ETF
Compare NATCAPSUQ with any stock or ETF
NATCAPSUQ
Loading...

NATCAPSUQ Holdings

NATCAPSUQ Shareholdings

NATCAPSUQ Promoter Holdings Trend

NATCAPSUQ Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

NATCAPSUQ Institutional Holdings Trend

NATCAPSUQ Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

NATCAPSUQ Shareholding Pattern

NATCAPSUQ Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.21%0.00%0.00%0.00%48.79%

Nov 2024

Dec 2024

Feb 2025

Mar 2025

NATCAPSUQ Shareholding History

NATCAPSUQ Shareholding History

JunSepNovDec '24FebMar0.00%0.00%0.00%0.00%0.00%0.00%

NATCAPSUQ Insider Trades & Bulk Stock Deals

NATCAPSUQ Insider Trades & Bulk Stock Deals

Loading...

smallcases containing NATCAPSUQ stock

smallcases containing NATCAPSUQ stock

Looks like this stock is not in any smallcase yet.

NATCAPSUQ Events

NATCAPSUQ Events

NATCAPSUQ Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

NATCAPSUQ Dividend Trend

No dividend trend available

NATCAPSUQ Upcoming Dividends

NATCAPSUQ Upcoming Dividends

No upcoming dividends are available

NATCAPSUQ Past Dividends

NATCAPSUQ Past Dividends

Cash Dividend

Ex DateEx DateJul 20, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 20, 2023

Cash Dividend

Ex DateEx DateSep 9, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 9, 2022

Cash Dividend

Ex DateEx DateJul 6, 2021

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 6, 2021

Cash Dividend

Ex DateEx DateAug 12, 2020

Final
Final | Div/Share: ₹0.60

Dividend/Share

₹0.60

Ex DateEx Date

Aug 12, 2020

Cash Dividend

Ex DateEx DateAug 13, 2019

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Aug 13, 2019

NATCAPSUQ Stock News & Opinions

NATCAPSUQ Stock News & Opinions

Earnings
Natural Capsules consolidated net profit declines 46.39% in the March 2025 quarter

Net profit of Natural Capsules declined 46.39% to Rs 0.52 crore in the quarter ended March 2025 as against Rs 0.97 crore during the previous quarter ended March 2024. Sales rose 11.81% to Rs 44.97 crore in the quarter ended March 2025 as against Rs 40.22 crore during the previous quarter ended March 2024. For the full year,net profit declined 88.83% to Rs 0.62 crore in the year ended March 2025 as against Rs 5.55 crore during the previous year ended March 2024. Sales rose 8.87% to Rs 169.21 crore in the year ended March 2025 as against Rs 155.42 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales44.9740.22 12 169.21155.42 9 OPM %9.7610.22 -10.3512.81 - PBDT3.053.63 -16 11.9116.72 -29 PBT0.891.43 -38 2.798.05 -65 NP0.520.97 -46 0.625.55 -89 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Natural Capsules declare Quarterly Result

Natural Capsules will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Natural Capsules consolidated net profit declines 90.91% in the December 2024 quarter

Net profit of Natural Capsules declined 90.91% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 1.21 crore during the previous quarter ended December 2023. Sales rose 9.63% to Rs 43.83 crore in the quarter ended December 2024 as against Rs 39.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales43.8339.98 10 OPM %9.7411.81 - PBDT2.843.98 -29 PBT0.501.79 -72 NP0.111.21 -91 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Natural Capsules schedules board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Natural Capsules reports consolidated net loss of Rs 0.61 crore in the September 2024 quarter

Net loss of Natural Capsules reported to Rs 0.61 crore in the quarter ended September 2024 as against net profit of Rs 1.56 crore during the previous quarter ended September 2023. Sales rose 9.86% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 37.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales41.2237.52 10 OPM %10.9213.65 - PBDT2.964.31 -31 PBT0.622.14 -71 NP-0.611.56 PL Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Natural Capsules to hold board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Natural Capsules consolidated net profit declines 67.03% in the June 2024 quarter

Net profit of Natural Capsules declined 67.03% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales rose 3.93% to Rs 39.18 crore in the quarter ended June 2024 as against Rs 37.70 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales39.1837.70 4 OPM %11.1315.81 - PBDT3.054.80 -36 PBT0.772.69 -71 NP0.601.82 -67 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live
Corporate
Natural Capsules schedules EGM

Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 August 2024 .Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Natural Capsules Ltd (NATCAPSUQ) today?

    The share price of NATCAPSUQ as on 8th July 2025 is ₹214.89. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Natural Capsules Ltd (NATCAPSUQ) share?

    The past returns of Natural Capsules Ltd (NATCAPSUQ) share are
    • Past 1 week: -5.98%
    • Past 1 month: -7.17%
    • Past 3 months: 13.57%
    • Past 6 months: -19.17%
    • Past 1 year: -32.82%
    • Past 3 years: -52.89%
    • Past 5 years: 465.90%

  3. What are the peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ)?

    The peers or stocks similar to Natural Capsules Ltd (NATCAPSUQ) include:

  4. What is the market cap of Natural Capsules Ltd (NATCAPSUQ) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Natural Capsules Ltd (NATCAPSUQ) is ₹226.25 Cr as of 8th July 2025.

  5. What is the 52 week high and low of Natural Capsules Ltd (NATCAPSUQ) share?

    The 52-week high of Natural Capsules Ltd (NATCAPSUQ) is ₹376.90 and the 52-week low is ₹164.

  6. What is the PE and PB ratio of Natural Capsules Ltd (NATCAPSUQ) stock?

    The P/E (price-to-earnings) ratio of Natural Capsules Ltd (NATCAPSUQ) is 370.91. The P/B (price-to-book) ratio is 0.99.

  7. Which sector does Natural Capsules Ltd (NATCAPSUQ) belong to?

    Natural Capsules Ltd (NATCAPSUQ) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Natural Capsules Ltd (NATCAPSUQ) shares?

    You can directly buy Natural Capsules Ltd (NATCAPSUQ) shares on Tickertape. Simply sign up, connect your demat account and place your order.